Free Trial

Pensionfund DSM Netherlands Sells 12,000 Shares of National Health Investors, Inc. (NYSE:NHI)

National Health Investors logo with Finance background

Pensionfund DSM Netherlands trimmed its holdings in National Health Investors, Inc. (NYSE:NHI - Free Report) by 60.0% in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 8,000 shares of the real estate investment trust's stock after selling 12,000 shares during the period. Pensionfund DSM Netherlands' holdings in National Health Investors were worth $554,000 as of its most recent filing with the Securities and Exchange Commission.

Other institutional investors have also recently made changes to their positions in the company. Quarry LP bought a new stake in shares of National Health Investors during the third quarter valued at about $27,000. Strategic Financial Concepts LLC bought a new stake in National Health Investors during the second quarter valued at $28,000. Covestor Ltd increased its stake in National Health Investors by 2,700.0% in the 3rd quarter. Covestor Ltd now owns 420 shares of the real estate investment trust's stock worth $35,000 after acquiring an additional 405 shares during the last quarter. Point72 DIFC Ltd bought a new stake in shares of National Health Investors during the 3rd quarter valued at about $35,000. Finally, Loomis Sayles & Co. L P purchased a new position in shares of National Health Investors during the third quarter worth about $38,000. Hedge funds and other institutional investors own 62.51% of the company's stock.

Wall Street Analysts Forecast Growth

NHI has been the topic of several research reports. StockNews.com cut shares of National Health Investors from a "buy" rating to a "hold" rating in a research report on Tuesday, October 15th. Truist Financial cut their price objective on National Health Investors from $78.00 to $72.00 and set a "hold" rating for the company in a report on Monday, December 23rd. Wells Fargo & Company lowered National Health Investors from an "overweight" rating to an "equal weight" rating and upped their target price for the stock from $81.00 to $86.00 in a research note on Tuesday, October 1st. Finally, Bank of America initiated coverage on shares of National Health Investors in a research note on Tuesday, September 24th. They issued a "buy" rating and a $92.00 price objective for the company. Three equities research analysts have rated the stock with a hold rating and four have given a buy rating to the company. According to data from MarketBeat.com, the company currently has an average rating of "Moderate Buy" and an average price target of $75.33.

View Our Latest Report on National Health Investors

National Health Investors Trading Down 3.3 %

NYSE NHI traded down $2.29 on Monday, hitting $66.91. The company's stock had a trading volume of 223,342 shares, compared to its average volume of 270,042. The company has a current ratio of 10.29, a quick ratio of 10.29 and a debt-to-equity ratio of 0.92. National Health Investors, Inc. has a 52-week low of $51.59 and a 52-week high of $86.13. The firm has a market cap of $3.04 billion, a P/E ratio of 22.99, a PEG ratio of 4.86 and a beta of 1.06. The company's 50-day simple moving average is $74.60 and its 200 day simple moving average is $75.87.

National Health Investors (NYSE:NHI - Get Free Report) last issued its quarterly earnings results on Tuesday, November 5th. The real estate investment trust reported $0.65 EPS for the quarter, missing analysts' consensus estimates of $1.07 by ($0.42). The company had revenue of $63.32 million during the quarter, compared to the consensus estimate of $67.93 million. National Health Investors had a return on equity of 10.11% and a net margin of 38.53%. The business's revenue for the quarter was up 1.7% compared to the same quarter last year. During the same period in the prior year, the firm earned $1.08 earnings per share. Research analysts predict that National Health Investors, Inc. will post 4.42 EPS for the current fiscal year.

National Health Investors Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Wednesday, January 29th. Investors of record on Tuesday, December 31st will be given a $0.90 dividend. The ex-dividend date is Tuesday, December 31st. This represents a $3.60 annualized dividend and a yield of 5.38%. National Health Investors's dividend payout ratio (DPR) is presently 123.71%.

About National Health Investors

(Free Report)

Incorporated in 1991, National Health Investors, Inc NYSE: NHI is a real estate investment trust specializing in sale, leasebacks, joint-ventures, senior housing operating partnerships, and mortgage and mezzanine financing of need-driven and discretionary senior housing and medical investments. NHI's portfolio consists of independent living, assisted living and memory care communities, entrance-fee retirement communities, skilled nursing facilities, and specialty hospitals.

See Also

Institutional Ownership by Quarter for National Health Investors (NYSE:NHI)

Should You Invest $1,000 in National Health Investors Right Now?

Before you consider National Health Investors, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and National Health Investors wasn't on the list.

While National Health Investors currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

These 7 Stocks Will Be Magnificent in 2025 Cover

Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2025. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Goldman Sachs’ 2025 Market Outlook: Top 3 Stock Picks
7 Stocks to Benefit From Trump’s Tariffs in 2025
Investing in Quantum Computing: Is Rigetti the Stock to Watch?

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines